ReviewAnnals of the rheumatic diseases2000
Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences.
Review in Annals of the rheumatic diseases, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Candidate's single-nucleotide polymorphism predictors of treatment nonresponse to the first anti-TNF inhibitor in ankylosing spondylitis.Rheumatology international · 2014Article
- Power Doppler ultrasonography in the evaluation of infliximab treatment for sacroiliitis in patients with ankylosing spondylitis.Rheumatology international · 2013Article
- Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis.Annals of the rheumatic diseases · 2006Article
- Infliximab: in ankylosing spondylitis.Drugs · 2005Review
- Expanding the armamentarium for the spondyloarthropathies.Arthritis research & therapy · 2004Review
- Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis.Drugs · 2004Review
- Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review.Annals of the rheumatic diseases · 2003Review
- Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19 January 2002.Annals of the rheumatic diseases · 2002Article
- Juvenile onset spondyloarthropathies: therapeutic aspects.Annals of the rheumatic diseases · 2002Review
- Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience.Annals of the rheumatic diseases · 2002Review
- Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.Arthritis research · 2002Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.